First anticipated ZEVASKYN® patient treatment shifted to 4Q 2025 following implementation of optimized release assay -- ...

Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous guidance of first half ...

Digital anthropologist Dr Payal Arora, Professor of Inclusive AI Cultures at Utrecht University, speaks to Ahram Online about ...

First anticipated ZEVASKYN® patient treatment shifted to 4Q 2025 following implementation of optimized release assay - - Strong and growing patient demand and treatment site network, along with broad ...

Tucked away in the heart of Tupelo, Mississippi exists a bargain hunter’s paradise where the thrill of discovery meets the joy of an incredible deal. The Tupelo Flea Market stands as a monument to the ...

KRRO-110 produced functional protein in Alpha-1 Antitrypsin Deficiency (AATD) patients —KRRO-110 did not reach projected levels of functional protein following a single administration —Pivoting to ...

Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) released its third quarter 2025 financial results today. All amounts are in U.S.

Ever been obsessed with a certain look, but you can’t describe it? From Frutiger Aero to Utopian Scholastic, Cari gives your ...

Hudbay Minerals Inc. ("Hudbay" or the "Company") (TSX, NYSE: HBM) released its third quarter 2025 financial results today. All amounts are in U.S. dollars, ...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for ...